Renata H Mullen, MD
Dermatology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Offices
- 2
Offices
2 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Mullen’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence C42155 · Current
Licensed to practise in California · since 1986 · expires 2027-07-31 · Tulane University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$176,184
Medicare paid this office $176,184 for 597 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 370 | $37,230 | $75 |
| Return visit (30+ min) | 236 | $32,183 | $103 |
| Destruction of precancer skin growth, 1 growth | 285 | $19,184 | $52 |
| Biopsy of related skin growth, first growth | 160 | $18,270 | $90 |
| Test for allergy using skin patch | 34 | $15,957 | $5 |
See all 12 services
| Short return visit (20+ min) | 370 | $37,230 | $75 |
| Return visit (30+ min) | 236 | $32,183 | $103 |
| Destruction of precancer skin growth, 1 growth | 285 | $19,184 | $52 |
| Biopsy of related skin growth, first growth | 160 | $18,270 | $90 |
| Test for allergy using skin patch | 34 | $15,957 | $5 |
| Destruction of precancer skin growth, 15 or more growths | 55 | $12,952 | $158 |
| Destruction of precancer skin growth, 2-14 growths | 217 | $9,181 | $7 |
| Destruction of skin growth, 1-14 growths | 60 | $7,928 | $110 |
| Short return visit | 123 | $5,964 | $44 |
| Long return visit (40+ min) | 28 | $4,952 | $155 |
| Biopsy of related skin growth, each additional growth | 48 | $3,135 | $48 |
| Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | 20 | $2,784 | $111 |
Procedures Medicare counted
| Removal of skin lesions | 755 | More than 91% of doctors who do this |
| Removal or shaving of skin growth | 59 | More than 81% of doctors who do this |
| Skin biopsy | 236 | More than 87% of doctors who do this |
Who their Medicare patients are
597 Original Medicare patients in 2024. Average age 77 · Women 69% · Health risk score 0.79. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 53% · Coronary heart disease 20% · Cancer 16% · Atrial fibrillation 15% · Chronic kidney disease 13% · Diabetes 11% · Depression 10% · Heart failure 6% · COPD 6% · Stroke 4% · Dementia 3%.
The office billed $679,562, Medicare allowed $251,079 and paid $176,184; for 6,228 services of 31 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 597 | 6,228 | 77 | 0.79 | $679,562 | $176,184 |
| 2023 | 573 | 4,559 | 77 | 0.78 | $621,483 | $178,827 |
| 2022 | 590 | 5,112 | 77 | 0.77 | $599,552 | $169,052 |
| 2021 | 563 | 3,814 | 77 | 0.79 | $517,389 | $155,620 |
| 2020 | 524 | 2,737 | 76 | 0.80 | $397,919 | $105,945 |
| 2019 | 699 | 4,866 | 76 | 0.80 | $593,138 | $158,350 |
| 2018 | 653 | 3,882 | 76 | 0.81 | $542,601 | $149,493 |
| 2017 | 622 | 4,288 | 76 | 0.80 | $510,962 | $140,377 |
| 2016 | 623 | 3,157 | 76 | 0.82 | $424,906 | $115,834 |
| 2015 | 574 | 3,575 | 76 | 0.85 | $437,489 | $125,113 |
| 2014 | 542 | 3,463 | 75 | 0.77 | $365,500 | $104,713 |
| 2013 | 437 | 2,525 | 75 | 0.82 | $308,143 | $81,644 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Return visit (30+ min) | 249 | $35,743 | $108 |
| Short return visit (20+ min) | 341 | $33,482 | $78 |
| Biopsy of related skin growth, first growth | 170 | $20,737 | $101 |
| Destruction of precancer skin growth, 1 growth | 257 | $17,671 | $55 |
| Destruction of precancer skin growth, 15 or more growths | 59 | $13,474 | $168 |
| Destruction of skin growth, 1-14 growths | 75 | $10,595 | $116 |
| Test for allergy using skin patch | 17 | $8,515 | $5 |
| Destruction of precancer skin growth, 2-14 growths | 199 | $8,057 | $7 |
| Short return visit | 128 | $7,461 | $50 |
| Long return visit (40+ min) | 21 | $4,184 | $161 |
| Biopsy of related skin growth, each additional growth | 40 | $2,838 | $52 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 11 | $2,303 | $154 |
| Punch biopsy, first skin growth | 16 | $2,240 | $132 |
| New patient visit (15+ min) | 13 | $774 | $60 |
2022: 15 services
| Short return visit (20+ min) | 377 | $36,572 | $73 |
| Return visit (30+ min) | 215 | $28,510 | $101 |
| Destruction of precancer skin growth, 1 growth | 274 | $18,709 | $52 |
| Biopsy of related skin growth, first growth | 145 | $17,255 | $99 |
| Test for allergy using skin patch | 24 | $10,879 | $5 |
| Destruction of precancer skin growth, 15 or more growths | 47 | $9,409 | $168 |
| Destruction of precancer skin growth, 2-14 growths | 207 | $9,106 | $7 |
| Destruction of skin growth, 1-14 growths | 59 | $7,318 | $106 |
| Short return visit | 123 | $7,286 | $51 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 21 | $4,181 | $174 |
| Punch biopsy, first skin growth | 33 | $4,168 | $126 |
| Long return visit (40+ min) | 19 | $2,792 | $140 |
| Biopsy of related skin growth, each additional growth | 25 | $1,890 | $54 |
| New patient visit (30+ min) | 18 | $1,859 | $103 |
| New patient visit (15+ min) | 11 | $635 | $58 |
2021: 12 services
| Short return visit (20+ min) | 357 | $34,545 | $73 |
| Return visit (30+ min) | 197 | $26,737 | $107 |
| Destruction of precancer skin growth, 1 growth | 259 | $18,382 | $52 |
| Biopsy of related skin growth, first growth | 144 | $16,710 | $101 |
| Destruction of precancer skin growth, 15 or more growths | 50 | $10,611 | $163 |
| Destruction of precancer skin growth, 2-14 growths | 200 | $9,583 | $7 |
| Destruction of skin growth, 1-14 growths | 62 | $9,521 | $116 |
| Short return visit | 122 | $6,553 | $47 |
| Punch biopsy, first skin growth | 24 | $3,594 | $133 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 17 | $3,293 | $173 |
| Biopsy of related skin growth, each additional growth | 25 | $1,690 | $56 |
| New patient visit (30+ min) | 17 | $1,345 | $79 |
2020: 11 services
| Short return visit (20+ min) | 338 | $24,400 | $57 |
| Return visit (30+ min) | 134 | $16,135 | $93 |
| Biopsy of related skin growth, first growth | 136 | $13,642 | $88 |
| Destruction of precancer skin growth, 1 growth | 213 | $12,707 | $47 |
| Destruction of skin growth, 1-14 growths | 57 | $6,786 | $108 |
| Destruction of precancer skin growth, 15 or more growths | 30 | $5,611 | $148 |
| Destruction of precancer skin growth, 2-14 growths | 156 | $5,347 | $6 |
| Short return visit | 95 | $4,056 | $37 |
| Punch biopsy, first skin growth | 24 | $2,735 | $114 |
| Biopsy of related skin growth, each additional growth | 33 | $2,465 | $52 |
| New patient visit (15+ min) | 17 | $877 | $52 |
2019: 14 services
| Short return visit (20+ min) | 398 | $32,103 | $60 |
| Biopsy of related skin growth, first growth | 196 | $21,722 | $88 |
| Return visit (30+ min) | 155 | $18,416 | $86 |
| Destruction of precancer skin growth, 1 growth | 268 | $17,101 | $48 |
| Destruction of skin growth, 1-14 growths | 94 | $11,630 | $105 |
| Destruction of precancer skin growth, 15 or more growths | 51 | $9,613 | $139 |
| Test for allergy using skin patch | 18 | $8,439 | $6 |
| Short return visit | 181 | $8,076 | $38 |
| Destruction of precancer skin growth, 2-14 growths | 209 | $7,555 | $5 |
| Punch biopsy, first skin growth | 46 | $5,488 | $119 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 14 | $4,388 | None |
| Biopsy of related skin growth, each additional growth | 53 | $3,834 | $53 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 13 | $2,407 | $150 |
| New patient visit (15+ min) | 18 | $1,035 | $57 |
2018: 14 services
| Short return visit (20+ min) | 398 | $29,395 | $57 |
| Biopsy of single growth of skin and/or tissue | 211 | $23,394 | $93 |
| Return visit (30+ min) | 196 | $21,704 | $87 |
| Destruction of precancer skin growth, 1 growth | 268 | $17,000 | $50 |
| Destruction of skin growth, 1-14 growths | 72 | $9,029 | $109 |
| Destruction of precancer skin growth, 15 or more growths | 55 | $8,873 | $127 |
| Short return visit | 180 | $8,505 | $37 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 18 | $7,613 | None |
| Destruction of precancer skin growth, 2-14 growths | 206 | $5,926 | $5 |
| Biopsy of each additional growth of skin and/or tissue | 61 | $2,645 | $31 |
| Application of light to destroy precancer skin growth | 16 | $2,429 | $121 |
| Injection into skin growth, 1-7 growths | 15 | $1,721 | $42 |
| New patient visit (15+ min) | 27 | $1,316 | $49 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $46 | None |
2017: 15 services
| Short return visit (20+ min) | 404 | $32,232 | $59 |
| Biopsy of single growth of skin and/or tissue | 187 | $20,813 | $96 |
| Return visit (30+ min) | 192 | $20,146 | $85 |
| Destruction of precancer skin growth, 1 growth | 270 | $18,599 | $52 |
| Destruction of precancer skin growth, 15 or more growths | 56 | $10,121 | $133 |
| Short return visit | 167 | $7,464 | $38 |
| Destruction of precancer skin growth, 2-14 growths | 222 | $7,089 | $5 |
| Test for allergy using skin patch | 13 | $5,624 | $6 |
| Destruction of skin growth, 1-14 growths | 38 | $4,406 | $102 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 12 | $2,128 | $142 |
| Biopsy of each additional growth of skin and/or tissue | 47 | $1,934 | $31 |
| New patient visit (15+ min) | 33 | $1,926 | $58 |
| Injection into skin growth, 1-7 growths | 14 | $1,853 | $48 |
| New patient visit (10+ min) | 11 | $296 | $27 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 13 | $47 | None |
2016: 12 services
| Short return visit (20+ min) | 417 | $31,813 | $58 |
| Return visit (30+ min) | 184 | $18,747 | $85 |
| Destruction of precancer skin growth, 1 growth | 255 | $17,048 | $53 |
| Biopsy of single growth of skin and/or tissue | 159 | $16,116 | $96 |
| Destruction of precancer skin growth, 15 or more growths | 49 | $7,980 | $138 |
| Destruction of precancer skin growth, 2-14 growths | 207 | $6,425 | $5 |
| Short return visit | 119 | $5,183 | $36 |
| Destruction of skin growth, 1-14 growths | 31 | $3,249 | $102 |
| New patient visit (15+ min) | 33 | $1,666 | $50 |
| Biopsy of each additional growth of skin and/or tissue | 31 | $1,164 | $31 |
| New patient visit (30+ min) | 11 | $939 | $85 |
| New patient visit (10+ min) | 16 | $417 | $26 |
2015: 13 services
| Short return visit (20+ min) | 325 | $27,407 | $61 |
| Return visit (30+ min) | 205 | $23,887 | $96 |
| Biopsy of single growth of skin and/or tissue | 181 | $21,315 | $101 |
| Destruction of precancer skin growth, 1 growth | 247 | $17,501 | $54 |
| Destruction of precancer skin growth, 2-14 growths | 197 | $6,769 | $6 |
| Short return visit | 122 | $5,983 | $38 |
| Destruction of skin growth, 1-14 growths | 38 | $4,705 | $109 |
| Destruction of precancer skin growth, 15 or more growths | 13 | $2,137 | $142 |
| New patient visit (15+ min) | 35 | $1,805 | $52 |
| New patient visit (30+ min) | 19 | $1,804 | $95 |
| Biopsy of each additional growth of skin and/or tissue | 36 | $1,345 | $32 |
| New patient visit (10+ min) | 16 | $394 | $25 |
| All potassium hydroxide (koh) preparations | 11 | $63 | $6 |
2014: 12 services
| Short return visit (20+ min) | 368 | $27,642 | $59 |
| Destruction of precancer skin growth, 1 growth | 220 | $17,053 | $59 |
| Biopsy of single growth of skin and/or tissue | 151 | $16,588 | $95 |
| Destruction of precancer skin growth, 2-14 growths | 168 | $9,694 | $10 |
| Return visit (30+ min) | 60 | $7,129 | $94 |
| Short return visit | 132 | $6,345 | $36 |
| Test for allergy using skin patch | 15 | $5,674 | $5 |
| New patient visit (15+ min) | 47 | $2,726 | $58 |
| Destruction of skin growth, 1-14 growths | 17 | $1,942 | $108 |
| Application of ultraviolet light to skin | 14 | $1,317 | $20 |
| Biopsy of each additional growth of skin and/or tissue | 27 | $963 | $30 |
| New patient visit (10+ min) | 16 | $535 | $33 |
2013: 10 services
| Short return visit (20+ min) | 312 | $23,688 | $57 |
| Destruction of precancer skin growth, 1 growth | 174 | $14,455 | $67 |
| Biopsy of single growth of skin and/or tissue | 124 | $13,944 | $96 |
| Short return visit | 109 | $5,306 | $36 |
| Return visit (30+ min) | 43 | $4,730 | $89 |
| Destruction of precancer skin growth, 2-14 growths | 131 | $4,627 | $6 |
| New patient visit (15+ min) | 32 | $1,855 | $58 |
| Application of ultraviolet light to skin | 12 | $1,637 | $23 |
| Biopsy of each additional growth of skin and/or tissue | 30 | $1,036 | $30 |
| New patient visit (10+ min) | 12 | $346 | $29 |
Drugs they prescribed that Part D paid
$81,088
Pharmacies billed $81,088 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 452) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
417 generic and 35 brand-name prescriptions · $81,088 in drug cost · 16 antibiotic prescriptions to 13 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Dupixent | 14 | $49,770 | $3,555 |
| Fluorouracil | 24 | $1,760 | $73 |
| Metronidazole | 14 | $1,483 | $106 |
| Azelaic Acid | 14 | $1,327 | $95 |
| Ciclopirox | 43 | $1,145 | $27 |
See all 15 drugs
| Dupixent | 14 | $49,770 | $3,555 |
| Fluorouracil | 24 | $1,760 | $73 |
| Metronidazole | 14 | $1,483 | $106 |
| Azelaic Acid | 14 | $1,327 | $95 |
| Ciclopirox | 43 | $1,145 | $27 |
| Fluocinolone Acetonide | 25 | $717 | $29 |
| Fluocinonide | 42 | $713 | $17 |
| Valacyclovir | 25 | $565 | $23 |
| Betamethasone Diprop Augmented | 21 | $313 | $15 |
| Ketoconazole | 25 | $278 | $11 |
| Triamcinolone Acetonide | 34 | $276 | $8 |
| Clobetasol Propionate | 18 | $221 | $12 |
| Doxycycline Monohydrate | 14 | $180 | $13 |
| Minoxidil | 17 | $165 | $10 |
| Hydrocortisone | 23 | $105 | $5 |
Year by year
| 2024 | 452 | 208 | 0% (0) | 8% | $81,088 |
| 2023 | 416 | 207 | 0% (0) | 5% | $24,950 |
| 2022 | 486 | 216 | 0% (0) | 9% | $72,162 |
| 2021 | 487 | 224 | 0% (0) | 6% | $44,358 |
| 2020 | 369 | 177 | 0% (0) | 11% | $99,907 |
| 2019 | 389 | 204 | 0% (0) | 13% | $103,785 |
| 2018 | 390 | 204 | 0% (0) | 19% | $112,361 |
| 2017 | 447 | 227 | 0% (0) | 15% | $40,422 |
| 2016 | 391 | 206 | 0% (0) | 23% | $41,457 |
| 2015 | 371 | 177 | 0% (0) | 19% | $34,497 |
| 2014 | 321 | 175 | 0% (0) | 25% | $24,539 |
| 2013 | 390 | 181 | None | 27% | $31,520 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Metronidazole | 22 | $2,477 | $113 |
| Azelaic Acid | 15 | $1,592 | $106 |
| Clobetasol Propionate | 29 | $1,292 | $45 |
| Ciclopirox | 35 | $1,175 | $34 |
| Valacyclovir | 24 | $1,085 | $45 |
| Fluocinonide | 33 | $859 | $26 |
| Triamcinolone Acetonide | 69 | $561 | $8 |
| Ketoconazole | 21 | $340 | $16 |
| Doxycycline Monohydrate | 11 | $274 | $25 |
| Hydrocortisone | 19 | $167 | $9 |
| Minoxidil | 14 | $144 | $10 |
| Betamethasone Diprop Augmented | 14 | $133 | $10 |
2022: 14 drugs
| Azelaic Acid | 15 | $2,166 | $144 |
| Fluocinonide | 61 | $2,061 | $34 |
| Clobetasol Propionate | 33 | $1,929 | $58 |
| Metronidazole | 14 | $1,564 | $112 |
| Valacyclovir | 26 | $1,492 | $57 |
| Ciclopirox | 33 | $1,181 | $36 |
| Fluorouracil | 13 | $1,134 | $87 |
| Betamethasone Dipropionate | 14 | $814 | $58 |
| Triamcinolone Acetonide | 57 | $464 | $8 |
| Ketoconazole | 26 | $386 | $15 |
| Doxycycline Monohydrate | 19 | $305 | $16 |
| Hydrocortisone | 35 | $252 | $7 |
| Betamethasone Diprop Augmented | 11 | $184 | $17 |
| Gabapentin | 11 | $93 | $8 |
2021: 17 drugs
| Azelaic Acid | 19 | $2,835 | $149 |
| Fluorouracil | 24 | $2,390 | $100 |
| Metronidazole | 17 | $2,197 | $129 |
| Ciclopirox | 36 | $1,536 | $43 |
| Fluocinonide | 44 | $1,334 | $30 |
| Clobetasol Propionate | 33 | $893 | $27 |
| Betamethasone Dipropionate | 19 | $710 | $37 |
| Hydrocortisone | 46 | $700 | $15 |
| Doxycycline Hyclate | 16 | $657 | $41 |
| Fluocinolone Acetonide | 12 | $648 | $54 |
| Valacyclovir | 17 | $537 | $32 |
| Ketoconazole | 24 | $459 | $19 |
| Triamcinolone Acetonide | 49 | $456 | $9 |
| Econazole Nitrate | 17 | $328 | $19 |
| Fluticasone Propionate | 14 | $223 | $16 |
| Doxycycline Monohydrate | 11 | $221 | $20 |
| Betamethasone Diprop Augmented | 17 | $214 | $13 |
2020: 11 drugs
| Azelaic Acid | 15 | $3,128 | $209 |
| Metronidazole | 20 | $2,452 | $123 |
| Fluorouracil | 20 | $1,862 | $93 |
| Fluocinonide | 31 | $1,380 | $45 |
| Clobetasol Propionate | 23 | $1,361 | $59 |
| Valacyclovir | 24 | $770 | $32 |
| Doxycycline Hyclate | 11 | $637 | $58 |
| Triamcinolone Acetonide | 52 | $467 | $9 |
| Betamethasone Diprop Augmented | 24 | $417 | $17 |
| Doxycycline Monohydrate | 13 | $354 | $27 |
| Ketoconazole | 11 | $253 | $23 |
2019: 13 drugs
| Doxycycline Ir-Dr | 20 | $12,308 | $615 |
| Metronidazole | 32 | $3,947 | $123 |
| Azelaic Acid | 16 | $2,762 | $173 |
| Ciclopirox | 29 | $2,163 | $75 |
| Fluorouracil | 22 | $2,087 | $95 |
| Fluocinonide | 54 | $1,568 | $29 |
| Fluocinolone Acetonide | 11 | $1,085 | $99 |
| Valacyclovir | 25 | $812 | $32 |
| Clobetasol Propionate | 16 | $745 | $47 |
| Ketoconazole | 15 | $334 | $22 |
| Doxycycline Monohydrate | 12 | $306 | $25 |
| Econazole Nitrate | 11 | $276 | $25 |
| Triamcinolone Acetonide | 33 | $208 | $6 |
2018: 11 drugs
| Finacea | 12 | $3,779 | $315 |
| Clobetasol Propionate | 23 | $3,629 | $158 |
| Metronidazole | 24 | $2,757 | $115 |
| Fluorouracil | 25 | $2,597 | $104 |
| Ciclopirox | 30 | $2,278 | $76 |
| Fluocinonide | 42 | $2,194 | $52 |
| Triamcinolone Acetonide | 60 | $599 | $10 |
| Desonide | 12 | $579 | $48 |
| Valacyclovir | 19 | $523 | $28 |
| Econazole Nitrate | 14 | $467 | $33 |
| Ketoconazole | 11 | $335 | $30 |
2017: 13 drugs
| Metronidazole | 35 | $5,679 | $162 |
| Fluorouracil | 26 | $3,100 | $119 |
| Clobetasol Propionate | 20 | $2,876 | $144 |
| Ciclopirox | 32 | $2,627 | $82 |
| Fluocinonide | 60 | $2,599 | $43 |
| Fluocinolone Acetonide | 11 | $1,132 | $103 |
| Econazole Nitrate | 14 | $1,075 | $77 |
| Desonide | 21 | $996 | $47 |
| Triamcinolone Acetonide | 61 | $808 | $13 |
| Valacyclovir | 18 | $617 | $34 |
| Ketoconazole | 14 | $460 | $33 |
| Doxycycline Monohydrate | 14 | $264 | $19 |
| Prednisone | 15 | $114 | $8 |
2016: 15 drugs
| Doxycycline Ir-Dr | 11 | $8,359 | $760 |
| Metronidazole | 35 | $6,216 | $178 |
| Clobetasol Propionate | 28 | $4,329 | $155 |
| Fluocinonide | 64 | $3,296 | $51 |
| Econazole Nitrate | 20 | $2,651 | $133 |
| Fluorouracil | 16 | $2,292 | $143 |
| Ciclopirox | 19 | $1,774 | $93 |
| Fluocinolone Acetonide | 13 | $1,453 | $112 |
| Tretinoin | 17 | $1,394 | $82 |
| Clobetasol Emollient | 12 | $1,259 | $105 |
| Desonide | 13 | $506 | $39 |
| Triamcinolone Acetonide | 34 | $411 | $12 |
| Valacyclovir | 13 | $315 | $24 |
| Doxycycline Monohydrate | 14 | $306 | $22 |
| Mupirocin | 11 | $124 | $11 |
2015: 11 drugs
| Econazole Nitrate | 33 | $6,665 | $202 |
| Clobetasol Propionate | 26 | $4,026 | $155 |
| Metronidazole | 17 | $3,022 | $178 |
| Fluocinonide | 52 | $2,544 | $49 |
| Ciclopirox | 17 | $1,844 | $108 |
| Tretinoin | 15 | $1,537 | $102 |
| Desonide | 14 | $1,258 | $90 |
| Ketoconazole | 28 | $704 | $25 |
| Valacyclovir | 19 | $684 | $36 |
| Triamcinolone Acetonide | 30 | $569 | $19 |
| Doxycycline Monohydrate | 12 | $251 | $21 |
2014: 10 drugs
| Metronidazole | 18 | $3,006 | $167 |
| Clobetasol Propionate | 31 | $1,801 | $58 |
| Fluorouracil | 11 | $1,698 | $154 |
| Econazole Nitrate | 23 | $1,618 | $70 |
| Fluocinonide | 48 | $1,550 | $32 |
| Ciclopirox | 12 | $1,141 | $95 |
| Desonide | 17 | $655 | $39 |
| Ketoconazole | 22 | $423 | $19 |
| Triamcinolone Acetonide | 30 | $393 | $13 |
| Fluticasone Propionate | 16 | $236 | $15 |
2013: 13 drugs
| Metronidazole | 18 | $2,555 | $142 |
| Fluorouracil | 13 | $2,396 | $184 |
| Doxycycline Hyclate | 12 | $1,593 | $133 |
| Doxycycline Monohydrate | 12 | $1,305 | $109 |
| Fluocinonide | 57 | $1,291 | $23 |
| Clobetasol Propionate | 25 | $953 | $38 |
| Ciclopirox | 11 | $935 | $85 |
| Triamcinolone Acetonide | 34 | $895 | $26 |
| Fluticasone Propionate | 22 | $627 | $28 |
| Desonide | 17 | $621 | $37 |
| Econazole Nitrate | 26 | $480 | $18 |
| Metoprolol | 12 | $407 | $34 |
| Ketoconazole | 21 | $385 | $18 |
Money from drug and device companies
$688 in 2025
| 2025 | 11 | 22 | None | $688 |
| 2024 | 11 | 15 | None | $531 |
| 2023 | 2 | 2 | None | $140 |
| 2021 | 2 | 2 | None | $43 |
| 2020 | 4 | 4 | None | $79 |
| 2019 | 4 | 4 | None | $74 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Arcutis Biotherapeutics | Zoryve | $193 | 4 payments
|
| Sun Pharmaceutical Industries | Ilumya | $146 | 3 payments
|
| Incyte | Opzelura | $73 | 3 payments
|
| Galderma Laboratories L.P. | Nemluvio | $63 | 3 payments
|
| Lilly USA | Ebglyss | $52 | 2 payments
|
| Almirall | Klisyri | $45 | 2 payments
|
See all 22 published payments
| Amgen | Meals · 2025-12-10 | Otezla | $22 |
| Incyte | Meals · 2025-12-09 | Opzelura | $21 |
| Regeneron Healthcare Solutions | Meals · 2025-12-04 | Dupixent | $17 |
| Ucb | Meals · 2025-12-02 | Bimzelx | $30 |
| Sun Pharmaceutical Industries | Meals · 2025-11-17 | Winlevi | $14 |
| Sun Pharmaceutical Industries | Education · 2025-11-13 | None | $100 |
| Arcutis Biotherapeutics | Meals · 2025-11-08 | Zoryve | $129 |
| Sun Pharmaceutical Industries | Meals · 2025-10-21 | Ilumya | $32 |
| Organon | Meals · 2025-10-16 | Nexplanon | $16 |
| Galderma Laboratories L.P. | Meals · 2025-10-15 | Nemluvio | $24 |
| Incyte | Meals · 2025-10-08 | Opzelura | $22 |
| Arcutis Biotherapeutics | Meals · 2025-10-07 | Zoryve | $21 |
| Abbvie | Meals · 2025-09-02 | Skyrizi | $32 |
| Galderma Laboratories L.P. | Meals · 2025-08-21 | Nemluvio | $19 |
| Lilly USA | Meals · 2025-08-05 | Ebglyss | $27 |
| Arcutis Biotherapeutics | Meals · 2025-07-08 | Zoryve | $28 |
| Almirall | Meals · 2025-06-17 | Klisyri | $21 |
| Incyte | Meals · 2025-06-10 | Opzelura | $30 |
| Galderma Laboratories L.P. | Meals · 2025-03-11 | Nemluvio | $21 |
| Almirall | Meals · 2025-03-06 | Klisyri | $24 |
| Arcutis Biotherapeutics | Meals · 2025-02-18 | Zoryve | $14 |
| Lilly USA | Meals · 2025-02-11 | Ebglyss | $25 |
See earlier years (2024, 2023, 2021, 2020, 2019)
2024: $531
| Ucb | Bimzelx | $195 | 2 payments
|
| Abbvie | Skyrizi | $62 | 2 payments
|
| Lilly USA | Taltz | $48 | 2 payments
|
| Incyte | Opzelura | $47 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $36 | 1 payment
|
| STRATA Skin Sciences | Xtrac | $29 | 1 payment
|
| Galderma Laboratories L.P. | None | $28 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $28 | 1 payment
|
| Pfizer | Eucrisa | $25 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $19 | 1 payment
|
| LEO Pharma | Adbry | $14 | 1 payment
|
2023: $140
| Abbvie | Rinvoq | $125 | 1 payment
|
| Pfizer | Cibinqo | $15 | 1 payment
|
2021: $43
| AbbVie | Skyrizi | $26 | 1 payment
|
| Almirall | Seysara | $17 | 1 payment
|
2020: $79
| AbbVie | Skyrizi | $22 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $21 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $20 | 1 payment
|
| Sun Pharmaceutical Industries | Ilumya | $15 | 1 payment
|
2019: $74
| Sun Pharmaceutical Industries | Ilumya | $23 | 1 payment
|
| AbbVie | Humira | $19 | 1 payment
|
| Lilly USA | Taltz | $18 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $15 | 1 payment
|
Professional record
- NPI
- 1760493068
- Licence
- CA C42155California C42155: Current · expires 2027-07-31
- Trained
- Tulane University School of Medicine, 1984
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-08-11
- NPI last updated
- 2020-03-03
- NPI record certified
- 2020-03-03
This is when the NPI record was last certified, not a medical board exam.